KRYS icon

Krystal Biotech
KRYS

Overview Fund Activity

12 hedge funds and large institutions have $31M invested in Krystal Biotech in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
12
Holders Change
-1
Holders Change %
-7.69%
% of All Funds
0.28%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
1
Increased
3
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$757K
2
BlackRock
BlackRock
New York
+$67K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$19K
4
KBC Group
KBC Group
Belgium
+$12.1K

Top Sellers

1
RCM
RA Capital Management
Massachusetts
-$2.06M
2
Goldman Sachs
Goldman Sachs
New York
-$232K
3
Squarepoint
Squarepoint
New York
-$114K
4
Millennium Management
Millennium Management
New York
-$81.6K
Name Holding Trade Value Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$12.1M – – –
RCM
2
RA Capital Management
Massachusetts
$5.01M -$2.06M -203,929 -29%
KCM
3
Knoll Capital Management
Florida
$3.03M – – –
HCM
4
Highbridge Capital Management
New York
$3.03M – – –
TCP
5
Tourbillon Capital Partners
New York
$2.55M – – –
BBA
6
Baker Bros. Advisors
New York
$2.02M – – –
AG
7
Artal Group
Luxembourg
$1.51M – – –
Vanguard Group
8
Vanguard Group
Pennsylvania
$1.51M +$757K +75,009 +101%
Millennium Management
9
Millennium Management
New York
$174K -$81.6K -8,070 -32%
BlackRock
10
BlackRock
New York
$75K +$67K +6,636 +833%
KBC Group
11
KBC Group
Belgium
$22K +$12.1K +1,225 +123%
Acadian Asset Management
12
Acadian Asset Management
Massachusetts
$19K +$19K +1,871 New
Goldman Sachs
13
Goldman Sachs
New York
– -$232K -22,036 Closed
Squarepoint
14
Squarepoint
New York
– -$114K -10,800 Closed